A multicultural group practicing yoga together in a bright studio

Pallas Health vs TMates: GLP-1 Comparison 2026

Pallas Health vs TMates: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated November 10, 20264 min read

Quick answer

Pallas Health and TMates both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Pallas Health	TMates
Best for	A dose-flat compounded price with provider care included and unusually detailed pharmacy and prescriber disclosure	Compounded GLP-1 with hands-on clinical touch
Medication type	Compounded semaglutide and tirzepatide (503A/503B partner pharmacies, six named); brand-name Wegovy, Ozempic, Mounjaro, Zepbound also offered cash-pay (never ranked or routed by RY, see editorialGuard)	Compounded GLP-1 with bundled clinical support
Pricing model	First month intro, then 12-week prepay ($597 sema / $897 tirz per 12 weeks); one flat price at every dose; no membership fee	Monthly subscription, dose-tier pricing
Semaglutide price	Compounded, $139/mo on the 12-month plan. Verified 2026-11-10.	Compounded, $158/mo on the 12-month plan ($1,900 billed per term); $175/mo on the 6-month plan; $217/mo on the 3-month plan; $249/mo month-to-month. Verified 2026-07-14.
Tirzepatide price	Compounded, $239/mo on the 12-month plan. Verified 2026-11-10.	From $167/mo (compounded tirzepatide, 12-month plan; $297/mo month-to-month)
Key watchout	The $139/mo figure is the annual-plan average; otherwise semaglutide is $199 every 4 weeks after a $139 first month. The platform launched in July 2026, so its standing price has no operating history yet; confirm plan term and renewal price at checkout. Its brand-name cash-pay prices run far above the manufacturers' own direct-pay programs.	The $158 headline is the compounded SEMAGLUTIDE plan (12-month term; $249/mo month-to-month). Tirzepatide costs more ($167/mo on a 12-month plan, $297 month-to-month), confirm your product and term at checkout
Price checked	Checked November 10, 2026 · an automated check re-read it November 10, 2026	Checked July 14, 2026 · an automated check re-read it November 10, 2026

When to choose Pallas Health

You want the same compounded price at every dose as you escalate
You want the pharmacy network and prescribers disclosed by name (six pharmacies named; prescriber NPIs posted)
You want provider care included in one price with no separate membership fee
You're comfortable with an annual plan for the lowest rate

Check current Pallas Health pricing →

When to choose TMates

You want a compounded program with clinical check-ins built in
You'd rather pay one bundled monthly fee than line items
You want responsive messaging with prescribers
You're comfortable with a longer onboarding intake in exchange for support

Check current TMates pricing →

Full reviews

Frequently asked questions

Is Pallas Health cheaper than TMates?

Pallas Health starts lower on semaglutide (Compounded, $139/mo on the 12-month plan. Verified 2026-11-10.). TMates starts lower on tirzepatide (From $167/mo (compounded tirzepatide, 12-month plan; $297/mo month-to-month)). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Pallas Health or TMates?

Pallas Health tends to win on semaglutide entry pricing; TMates tends to win on tirzepatide entry pricing. Pick by which medication you'll be on long-term, not by the cheapest entry tier.

Are Pallas Health and TMates compounded or brand-name?

Pallas Health offers compounded semaglutide and tirzepatide (503a/503b partner pharmacies, six named); brand-name wegovy, ozempic, mounjaro, zepbound also offered cash-pay (never ranked or routed by ry, see editorialguard). TMates offers compounded glp-1 with bundled clinical support. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Pallas Health to TMates?

Yes, switching between Pallas Health and TMates is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Pallas Health and TMates to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, $139/mo on the 12-month plan. Verified 2026-11-10. and Compounded, $158/mo on the 12-month plan ($1,900 billed per term); $175/mo on the 6-month plan; $217/mo on the 3-month plan; $249/mo month-to-month. Verified 2026-07-14. are starting tiers, not your guaranteed long-term cost.